September’s top news stories

19:00 EDT 4 Oct 2019 | Pharmaceutical Technology

Gavi Vaccine Alliance seeks $7. 4bn to immunise 300 million people Gavi, the Vaccine Alliance initiated a $7.4bn fundraising drive...

The post September’s top news stories appeared first on Pharmaceutical Technology.

Original Article: September’s top news stories


More From BioPortfolio on "September’s top news stories"

Quick Search

Relevant Topics

A vaccine is any preparation intended to produce immunity to a disease by stimulating the production of antibodies. It creates immunity but does not cause the disease. There are several differnt types of vaccine avalable; Killed microorganisms; which s...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...